BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) FCF Margin (2020 - 2026)

Updated

BridgeBio Pharma's FCF Margin was -29.36% in Q2 2026, up 44.15 percentage points from -73.51% a year earlier and up 72.10 percentage points from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) FCF Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, BridgeBio Pharma's FCF Margin was -61.06% through Jun 30, 2026, up 217.38 percentage points year-over-year; for FY2025, it was -89.03%, up 146.05 percentage points from FY2024.

  • FCF Margin shows a five-year change of +4847.71 percentage points (FY2020 to FY2025).
  • In earlier years, FCF Margin was -235.09% in FY2024 (+5451.53 pp), -5686.62% in FY2023 (-5140.16 pp), -546.46% in FY2022 (+186.77 pp) and -733.23% in FY2021 (+4203.51 pp).
  • The Q2 2026 figure marks the highest quarterly FCF Margin since Q2 2024.
  • Compared with a year earlier, FCF Margin has increased for four straight quarters, with an average year-over-year change of +892.60 percentage points over the last eight quarters.
  • The best year-over-year quarter for FCF Margin over five years was Q4 2021 (a gain of 79602.72 percentage points); the worst was Q3 2022 (a drop of 34751.88 percentage points).
  • Per Business Quant data, BBIO's FCF Margin in the three quarters before Q2 2026 was -101.46% (Q1 2026), -36.62% (Q4 2025) and -91.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn -29.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.36%
Mar 31, 2026 -101.46%
Dec 31, 2025 -36.62%
Sep 30, 2025 -91.17%
Jun 30, 2025 -73.51%
Mar 31, 2025 -170.82%
Dec 31, 2024 -3,321.54%
Sep 30, 2024 -6,614.31%
Jun 30, 2024 3,443.22%
Mar 31, 2024 -104.32%
Dec 31, 2023 -7,177.88%
Sep 30, 2023 -3,560.43%
Jun 30, 2023 -6,933.64%
Mar 31, 2023 -7,904.38%
Dec 31, 2022 -5,029.09%
Sep 30, 2022 -40,213.61%
Jun 30, 2022 -44.55%
Mar 31, 2022 -9,533.29%
Dec 31, 2021 -1,058.75%
Sep 30, 2021 -5,461.73%
API Access

BridgeBio Pharma FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY